Summary
In pancreatic lesions of non-obese diabetic (NOD) mice the expression of inducible nitric oxide synthase (iNOS) and of the cytokines interferongamma and interleukin-4 were studied. Strong iNOS expression as determined at the level of transcription, translation and of enzyme activity was associated with destructive insulitis as seen 8–10 days after cyclophosphamide treatment of 70- to 80-day-old female NOD mice. Immunohistochemistry showed iNOS associated with infiltrating macrophages but not in endocrine cells. The enhancement of iNOS after cyclophosphamide correlated with an increase of T-helper type 1 (Th1) associated interferon-gamma expression while T-helper type 2 (Th2) associated interleukin-4 was the dominant cytokine prior to cyclophosphamide and after diabetes onset. We conclude that insulitis in young NOD mice is carried by Th2 cells while cyclophosphamide enhanced insulitis is determined by Th1 cells. Macrophages show two different functional states in insulitis; strong iNOS expression in macrophages is associated with destructive insulitis.
Article PDF
Similar content being viewed by others
Abbreviations
- CY:
-
Cyclophosphamide
- FCS:
-
fetal calf serum
- iNOS:
-
inducible NO synthase
- NO:
-
nitric oxide
- NOD:
-
non-obese diabetic
- RT-PCR:
-
reverse transcriptase polymerase chain reaction
- TH1/2:
-
T-helper type 1/2
References
Lee K-U, Amano K, Yoon J-W (1988) Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 37: 989–991
Kröncke K-D, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H (1992) Activated macrophages kill pancreatic syngenic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 175: 752–758
Kallmann B, Burkart V, Kröncke K-D, Kolb-Bachofen V, Kolb H (1992) Toxicity of chemically generated nitrite oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51: 671–678
Corbett JA, Anwar M, Shimizu J et al. (1993) Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 90: 8992–8995
Shehadeh NN, LaRosa F, Lafferty KJ (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6: 291–300
Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB (1993) Insulin-dependent diabetes in the NOD mouse model II β cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15: 113–122
Kleemann R, Rothe H, Kolb-Bachofen V, Xie Q-W, Nathan C, Martin S, Kolb H (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 328: 9–12
Faust A, Burkart V, Ulrich H, Weischer CH, Kolb H (1994) Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int J Immunopharmac 16: 61–66
Mandrup-Poulsen T, Corbett JA, McDaniel ML, Nerup J (1993) What are the types and cellular sources of free radicals in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus? Diabetologia 36: 470–471
Campbell IL, Kay TWH, Oxbrow L, Harrison LC (1991) Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87: 739–742
Author information
Authors and Affiliations
Additional information
The contributions of H. Rothe and A. Faust to this paper should be considered as equal.
Rights and permissions
About this article
Cite this article
Rothe, H., Faust, A., Schade, U. et al. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37, 1154–1158 (1994). https://doi.org/10.1007/BF00418380
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00418380